Kowloon, Hong Kong (May 20, 2015) – Innokeys Pte Ltd attended the Asia Biotech Invest 2015 as one of the presenting companies. In total Asia Biotech Invest 2015 welcomed 22 biotech companies from around the world to present their R&D pipeline and investment memorandums. Dr. Rikrik Ilyas, CEO of Innokeys Pte Ltd, presentation covered Innokey’s product pipeline, current and future development opportunities, including plans for an upcoming expansion.
About the Event
Asia Biotech Invest 2015 is an annual biotech investment conference in Asia. Held at the Sheraton Hotel, the two-day conference and exhibition that started on May 20, 2015 has brought together over 200 attendees representing 160 companies from the life science community. This year, Asia Biotech Invest 2015 introduced two very exciting areas in Asia life science investments – digital health and medical device investment, both rising quickly in popularity. Asia Biotech Invest is an integrated event with Aus Biotech in Australia and Europe Biotech Invest in Europe.
Innokeys Pte Ltd is a Singapore based limited liability company that was set up to leverage the value of innovation in the field of healthcare, especially in biopharmaceuticals. Founded in 2012, by Johannes Setijono and Dr. Rikrik Ilyas, Innokeys activities include identification, acquisition, development and commercialization of suitable innovations. Innokeys also provides consulting and partnering services for the above activities.